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T cells expressing NK cell receptors (NKR) display rapid MHC-unrestricted cytotoxicity and
potent cytokine secretion and are thought to play roles in immunity against tumors. We have
quantified and characterized NKR+ T cells freshly isolated from epithelial and lamina propria
layers of duodenum and colon from 16 individuals with no evidence of gastrointestinal dis-
ease and from tumor and uninvolved tissue from 19 patients with colorectal cancer. NKR+ T
cell subpopulations were differentially distributed in different intestinal compartments, and
CD161+ T cells accounted for over one half of T cells at all locations tested. Most intestinal
CD161+ T cells expressed § g TCR and either CD4 or CD8. Significant proportions expressed
HLA-DR, CD69 and Fas ligand. Upon stimulation in vitro, CD161+ T cells produced IFN- + and
TNF- § but not IL-4. NKT cells expressing the V § 24V g 11 TCR, which recognizes CD1d, were
virtually absent from the intestine, but colonic cells produced IFN- + in response to the NKT
cell agonist ligand § -galactosylceramide. NKR+ T cells were not expanded in colonic tumors
compared to adjacent uninvolved tissue. The predominance, heterogeneity and differential
distribution of NKR+ T cells at different intestinal locations suggests that they are central to
intestinal immunity.
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1 Introduction
A minor subset of both murine and human T cells
expresses NK cell receptors (NKR) and displays func-
tional characteristics of NK cells and classical T cells
[1–4]. NKR+ T cells become activated rapidly after stimu-
lation, are capable of MHC-unrestricted cytotoxicity in
vitro and can secrete large amounts of cytokines includ-
ing IFN- + , TNF- § , IL-2 and IL-4 [5–7]. They account for
about 5% of peripheral blood lymphocytes but are
enriched in liver and bone marrow, accounting for
35–50% of lymphocytes in these organs [8, 9]. NKR can
act as inhibitory molecules on cloned T cells as shown
by in vitro models in CD3-TCR mediated cytolysis [10,
11]. Recently, NKR+ T cells that recoginize HLA-E mole-
cultes in association with peptides derived from MHC
class I molecules or viruses were described [12]
Although the mechanisms that control the expression of
NKR on T cells are not well understood, these receptors
are believed to function as costimulatory molecules or to
regulate effector T cell activity [13–16].
In mice, the majority of NKR+ T cells are NKT cells. NKT
cells express NK1.1 and an invariant TCR § -chain,
V § 14J § 18 (formerly V § 14J § 281), which preferentially
pairs with a limited number of g chains and recognizes
glycolipid antigens presented by the MHC class I-like
protein CD1d [17–19]. The natural ligand(s) for NKT cells
is unknown, but they respond to § -galactosylceramide
( § -GalCer), an extract of the marine sponge Agelas mau-
ritanius, in a CD1d-restricted manner [20, 21]. NKT cells
play key roles in immunity against tumors in some
murine models. Injection of mice with either IL-12 or § -
GalCer can result in tumor rejection by a mechanism that
is dependent on IFN- + production and/or anti-tumor
cytotoxicity by NKT cells [22, 23]. Furthermore, mice
deficient in NKT cells fail to mediate IL-12-induced rejec-
tion of tumors [24].
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CD1d-restricted NKT cells expressing invariant
V § 24J § 18 TCR § -chains (formerly V § 24J § Q) paired with
V g 11 have been identified in humans [25, 26], but they
are found in much lower numbers in blood ( ˚ 0.02% of
lymphocytes), liver and bone marrow ( X 1%) compared
to mice [9, 27]. However, human T cells expressing vari-
ous NKR, including CD56, CD57, CD161, CD94 and
killer Ig-like receptors, have been reported to share func-
tional similarities with invariant NKT cells, such as rapid
MHC-unrestricted cytotoxicity and potent cytokine
secretion [3, 4, 7]. Human NKR+ T cells are also thought
to play roles in anti-tumor immunity [5, 28, 29].
The human gastrointestinal tract contains several pheno-
typically and functionally distinct populations of T cells
[30–33]. Many of these cells are thought to play roles in
anti-tumor immunity. T cells isolated from the epithelial
layer and the lamina propria (LP) of the human colon are
cytotoxic and kill carcinoma cell lines in vitro [34, 35],
and T cell infiltration into tumor tissue is associated with
improved prognosis of colonic carcinoma [36, 37].
Recent studies have indicated that NKR+ T cells are also
present in murine and human intestine [38–40], but to
date no studies have addressed the potential roles of
these cells in intestinal cancer.
We have phenotypically and functionally characterized
NKR+ T cells in the epithelial and LP layers of non-
diseased human duodenum and colon and evaluated
changes in their numbers and phenotypes in patients
with colorectal cancer. Our results indicate that distinct
subsets of NKR+ T cells, but not invariant NKT cells,
accumulate at different intestinal locations. Many of
these cells express Fas ligand and markers of activation
and secrete inflammatory cytokines upon stimulation in
vitro. Colonic CD56+, CD57+ and CD161+ T cells were not
expanded in tumor tissue compared with adjacent unin-
volved tissue.
2 Results
2.1 Compartmentalization of NKR+ T cells in
human intestine
Flow cytometric analysis of single-cell suspensions pre-
pared from human colon and duodenum revealed differ-
ential distribution of NKR+ T cell populations in the epi-
thelium and LP (Fig. 1A). Approximately one half of all T
cells in both the epithelial (median 44.6%) and LP
(58.4%) layers of the colon expressed CD161 (Fig. 1B).
CD56 was expressed by smaller proportions of colonic T
cells, being present on a median of 35.1% of epithelial
layer T cells and on significantly lower numbers (22.4%;
p X 0.05) of LP T cells. CD57 was expressed by similar
proportions of colonic epithelial layer (8.2%) and LP
(9.8%) T cells as in peripheral blood (9.6%) (Fig. 1B).
When T cell subpopulations in duodenal tissue samples
were examined, CD161 was also found to be expressed
by the majority of epithelial layer (58.5%) and LP (57.5%)
T cells (Fig. 1B). Smaller proportions of T cells expressed
CD56, with significantly higher levels found in the LP
(19.6%) compared with the epithelium (10.9%; p X 0.05).
T cells expressing CD57 were less frequently detected in
both the epithelium (4.3%) and the LP (12.2%). The high
frequency of CD161+ cells in both the epithelial layer and
LP of human colon and the co-localization of CD161 and
CD3 were confirmed by immunohistochemistry and dou-
ble immunofluorescence (Fig. 1C, D).
2.2 Phenotypic characterization of intestinal
CD161+ T cells
In both human colon and duodenum, CD8 was
expressed by the majority of epithelial layer CD161+ T
cells (89.5% in colon and 59.9% in duodenum; Fig. 2A,
B), while smaller frequencies expressed CD4. In con-
trast, CD4 was expressed more frequently by CD161+ T
cells in the LP (58.5% in colon and 81.2% in duodenum;
Fig. 2A, B). Less than 5% of epithelial layer and LP
CD161+ T cells in both colon and duodenum expressed
neither CD4 nor CD8, a double-negative phenotype
commonly associated with NKT cells [17]. Analysis of
TCR phenotypes indicated that almost all CD161+ T cells
in both duodenal and colonic epithelium and LP layers
express § g TCR, while less than 3% expressed + ˇ TCR
(Fig. 2A, B). CD56 was expressed by X 20% of CD161+ T
cells at all intestinal locations tested (Fig. 2A, B).
The majority of total colonic CD161+ T cells expressed
the early activation marker CD69 (median 78.2%), and
up to 38.2% (median 18.4%) expressed the late activa-
tion marker HLA-DR (Fig. 2C). CD25 was expressed by a
smaller proportion of colonic CD161+ T cells (median
7.2%). Significant populations of intestinal CD161– T
cells also displayed activated phenotypes (Fig. 2C).
Expression of Fas ligand (CD95L) was significantly more
frequent in CD161+ T cells than in CD161– T cells (14.5%
vs. 1.8%; p X 0.05; Fig. 2C).
2.3 V > 24+V I 11+ NKT cells in human colon
It has previously been shown that, in most tissues, the
co-expression of the V § 24 and V g 11 TCR chains defines
invariant CD1d-restricted V § 24J § 18+ NKT cells [25, 26,
41, 42]. We used flow cytometry to detect V § 24J § 18+
NKT cells in human colon. The percentage of colonic
CD3+ T cells that expressed V § 24 ranged from 0.3% to
3.3% (median 1.0% in epithelium and 1.6% in LP;
Fig. 3A). However, these colonic epithelial and LP V § 24+
T cells did not co-express the V g 11 chain. In the liver, up
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P Fig. 1. NK receptor-positive T cells accumulate in the human
intestine. (A) Flow cytometric analysis of the co-expression
of CD3 with CD56, CD57 or CD161 on gated lymphocytes
from a non-diseased colon specimen. The numbers in the
upper right quadrants show the percentages of CD3+ cells
that express CD56, CD57 or CD161. (B) Percentages of
CD3+ cells that express CD56, CD57 or CD161 in the epithe-
lial (E) and LP layers of human colon (top, n=8) and duode-
num (middle, n=10) and in peripheral blood (bottom, n=7).
Horizontal bars indicate the median values. (C) Localization
of CD161+ cells by immunohistochemical staining in normal
colonic mucosa. CD161+ cells are indicated by brown
staining (×200). (D) Immunofluorescence staining for
CD3+CD161+ T cells in normal colon. Positive staining is
indicated by the greenish-yellow staining (×400).
to 90% (median 64.2%) of V § 24+ T cells expressed V g 11
(Fig. 3B) [27]. These data indicate that, while up to 1.6%
of hepatic T cells express V § 24V g 11 TCR, these invari-
ant NKT cells are present in extremely low numbers in
the human colon.
V § 24V g 11+ NKT cells specifically recognize § -GalCer
presented by CD1d [41, 42] which is expressed and is
functionally active in the murine and human intestine
[43–46]. We examined reactivity to § -GalCer in the
colonic cell preparations by culturing 1×106 cells with § -
GalCer and analyzing the culture supernatants for IFN- +
production. Levels of IFN- + were significantly up-
regulated by § -GalCer beyond levels detected in unstim-
ulated cultures (Fig. 3C).
2.4 Cytokine production by CD161+ T cells
The ability of freshly isolated colonic epithelial and LP
layer CD161– and CD161+ T cells to produce cytokines
upon stimulation in vitro was assessed by flow cyto-
metric analysis of permeabilized cells. Significant pro-
portions of CD161+ T cells produced IFN- + and TNF- § ,
but not IL-4, upon activation with PMA and ionomycin
(Fig. 4A). TNF- § was produced by significantly higher
frequencies of CD161+ T cells compared with CD161– T
cells from colonic epithelium (39.8% vs. 21.2%; p X 0.05)
and LP (69.7% vs. 57.1%; p X 0.05). In contrast, the fre-
quencies of colonic epithelial and LP CD161+ and
CD161– T cells that produced IFN- + in response to stimu-
lation were similar. The proportions of both CD161+ and
CD161– T cells that produced IL-4 upon PMA/ionomycin
stimulation was X 5% in all donors examined (Fig. 4B).
2.5 NKR+ T cells are not expanded in colonic
tumor tissue
Immunofluorescence studies on paired tumor and unin-
volved colon tissue sections from six patients with
colonic carcinoma (Fig. 1D) revealed that T cell numbers
were increased in the tumors in four patients and
decreased in two. The median numbers of CD3+ cells/
mm2 in tumor and uninvolved tissue from five patients
were 640 and 487, respectively (p not significant;
Fig. 5A). Flow cytometric analysis of these T cells
revealed that NKR+ T cells were not expanded in tumors.
The proportions of T cells that expressed CD161 and
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Fig. 2. Phenotypic characterization of CD161+ T cells freshly
isolated from human intestine. (A, B) Percentages of
CD3+CD161+ lymphocytes that express CD8, CD4, double-
negative CD8–CD4– (DN), § g TCR, + ˇ TCR and CD56 in the
epithelial and LP layers of human colon (A, n=7) and duode-
num (B, n=5). (C) Percentages of total CD3+CD161+ and
CD3+CD161– lymphocytes from normal colon (n=7) express-
ing HLA-DR, CD25, CD69 and Fas ligand. Horizontal bars
indicate median values.
Fig. 3. Invariant NKT cells do not accumulate in the human
colon. (A) Percentages of CD3+ cells that express V § 24 (left)
and V § 24V g 11 (right) TCR chains in epithelial (E) and LP lay-
ers of human colon (n=7) and blood (n=4). Horizontal bars
indicate median values. (B) Representative flow cytometry
dot plots showing V § 24 and V g 11 TCR chain expression by
gated CD3+ cells freshly isolated from normal colon, blood
and liver. Numbers show percentages of CD3+ cells that
express the V § 24V g 11 TCR. (C) Mean IFN- + levels released
by unstimulated, § -GalCer-stimulated and PHA-stimulated
total colonic cells (n=5). *p X 0.05.
CD56 were significantly reduced in tumors compared
with adjacent uninvolved tissue (medians 31.9% vs.
49.7% for CD161+ T cells and 8.6% vs. 19.9% for CD56+
T cells; p X 0.05; Fig. 5B). However, the absolute num-
bers of CD161+ and CD56+ T cells did not differ signifi-
cantly (medians 187 vs. 239 and 27 vs. 68 cells/mm2 in
tumors and adjacent uninvolved mucosa, respectively;
Fig. 5B). The proportions and absolute numbers of
CD57+ T cells were also unchanged in colonic tumors
(Fig. 5B).
V § 24+ T cells were also compared in tumor tissue and
adjacent mucosa in matched tissue specimens from five
patients. The percentages of V § 24+ T cells in normal
mucosa were low (0–2%), and the levels remained virtu-
ally undetectable in tumor tissues (data not shown).
3 Discussion
NKR+ T cells are predominantly localized in peripheral
tissues and have the capacity to rapidly kill tumor cells
and produce cytokines without the need for prior priming
with antigen [1–9]. We report here that the healthy adult
intestine is a site of accumulation of several distinct
NKR+ T cell populations that are differentially distributed
in the duodenum and colon and in the epithelial and LP
layers. In confirmation of previous studies [38, 39], we
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Fig. 4. Intracellular cytokine production by CD161+ and
CD161– T cells from normal colonic epithelium (E) and LP. (A)
Representative flow cytometry dot plots showing IFN- + ,
TNF- § and IL-4 expression by colonic CD161+ T cells stimu-
lated for 4 h with PMA and ionomycin. The percentages of
CD161+ cells that express the cytokines are indicated in the
upper right quadrants. (B) Median percentages of CD161+
and CD161– cells from epithelial and LP layers of 9 normal
colonic specimens that express IFN- + , TNF- § and IL-4 upon
stimulation (*p X 0.05).
Fig. 5. Colonic NKR+ T cells are not expanded in colonic
cancer. (A) Quantification of CD3+ cells per mm2 of paired
colonic carcinoma and adjacent uninvolved colonic mucosa
tissue sections in 5 patients using immunohistochemistry.
(B) Percentages (left) and absolute numbers (right) of CD3+
cells that express CD161, CD56 or CD57 in paired speimens
of tumor-involved tissue and adjacent uninvolved mucosa.
Horizontal bars indicate the median values (n=19 for per-
centages, n=5 for absolute numbers; *p X 0.05).
found that CD161+ T cells are among the most abundant
NKR+ T cell population in the intestine. These cells were
found to account for approximately one half of all T cells
in both the epithelial and LP layers of the duodenum and
colon. Compared to peripheral blood, CD56+ T cell num-
bers were elevated in the LP of the duodenum and colon
and the epithelial layer of the colon. CD57+ T cells were
found at similar frequencies in blood and the intestinal
compartments.
Our results indicate that almost all intestinal CD161+ T
cells express § g TCR. They can express CD4 or CD8,
but the majority in the epithelial layers of both the duode-
num and colon are CD8+, while CD4+ cells predominate
among CD161+ T cells in the LP. CD161+ T cells with the
double-negative (CD4–CD8–) phenotype commonly
associated with NKT cells [17–19] were rarely found in
the intestinal compartments tested. Colonic CD161– and
CD161+ T cells showed similar frequencies of expression
of the T cell activation markers CD25, CD69 and HLA-
DR, but Fas ligand (CD178) was found to be expressed
by higher frequencies of CD161+ than CD161– T cells in
the colon. Colonic CD161+ and CD161– T cells were
capable of rapid secretion of IFN- + and TNF- § , but little
IL-4, upon stimulation ex vivo with PMA and ionomycin.
The percentage of CD161+ T cells capable of producing
TNF- § was markedly higher when compared with
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CD161– T cells. These findings indicate that the majority
of CD161+ T cells in the intestine produce cytokines of
the Th1/Tc1 profile, consistent with a cytotoxic pheno-
type.
In the present study, we show that while the human
intestine contains large numbers of NKR+ T cells, very
low proportions of these express the invariant V § 24V g 11
TCR chain associated with CD1d restriction. Similar find-
ings have been reported for murine NKR+ T cells defined
by the co-expression of CD3 and NK1.1, which are rare
in the small intestine but accumulate in the colon [40]. In
contrast to murine liver, intestinal NKR+ T cells do not
express invariant V § 14J § 18 TCR or require CD1d for
their development [40]. However, CD1d is constitutively
expressed by murine and human intestinal epithelial cells
[43–46], suggesting that other non-invariant NKT cells
may be present in the intestine. In support of this, we
found that colonic mononuclear cells released significant
amounts of IFN- + after stimulation with § -GalCer in vitro.
§ -GalCer reactivity by human intraepithelial lymphocytes
(IEL) has also been recently demonstrated by Van de Wal
and co-workers [43], who showed that ligand recognition
is CD1d-dependent. The § -GalCer-reactive T cells in
human colon could either be invariant V § 24J § 18+ NKT
cells that are present in very low numbers but can rapidly
activate other cells, such as NK cells and conventional T
cells, to produce IFN- + . Alternatively, other non-invariant
NKT cells that recognize § -GalCer presented by CD1d
may be present in the colon and may be the primary
source of IFN- + . Non-invariant CD1d-restricted NKT
cells that express CD56 and/or CD161 have been
detected in human bone marrow [9] and in hepatitis C
virus-infected liver [47]. However, recent studies using
CD1d- § -GalCer tetramers have provided evidence that
§ -GalCer reactivity is restricted to V § 24V g 11+ NKT cells
[41, 42], which would argue against the notion of non-
invariant hepatic NKT cells recognizing § -GalCer. NKT
cells reactive with CD1 isotypes that are not found in
mice, namely CD1a, CD1b and CD1c [18], may also
reside within the CD56+/CD161+ T cell compartment of
the intestine.
CD56+ and CD161+ T cells can participate in anti-tumor
immune responses, being capable of potent anti-tumor
cytolytic activity and the production of large amounts of
inflammatory cytokines in vitro [5–7]. Flow cytometric
analysis of lymphocytes isolated from tumors and adja-
cent histologically normal colonic tissue from 19 patients
showed that the proportions of T cells that express CD56
or CD161 are significantly reduced in tumors. However,
while overall numbers were also reduced in tumors from
4 out of 5 patients, this reduction was not significant. We
also found that CD161+ T cells more frequently express
Fas ligand and produce more TNF- § than CD161– T
cells, suggesting that they are specialized for anti-tumor
cytotoxicity. Our observations that NKR+ T cells are not
expanded in tumors are not consistent with a role for
these cells in tumor immunity, but the reduction in the
proportions of NKR+ T cells could result in insufficient
activation of NK or cytolytic T cells required for efficient
clearing of tumor cells [48]. Alternatively, it could be the
result of activation-induced cell death of tumor-
infiltrating lymphocytes; apoptosis of tumor-infiltrating
lymphocytes was previously found to correlate with
lymph node metastases and poor prognosis in primary
colorectal cancer [49]. Changes in human NKR+ T cell
numbers, phenotypes and functions have also been
described in other malignancies [27–29, 50], although
their importance is less clear than in studies in mice
[22–24].
In conclusion, this study has shown that the human
intestine is a site where CD161+ T cells preferentially
accumulate, suggesting that these cells are important in
local immunity including resistance to tumor cell inva-
sion. CD161+ T cells frequently express Fas ligand and
produce IFN- + and TNF- § in response to stimulation.
Very small numbers of these cells express the invariant
V § 24V g 11 TCR, but reactivity against § -GalCer is
detectable among colonic cells, suggesting the pres-
ence of other CD1d-restricted NKT cells.
4 Materials and methods
4.1 Subjects
Sixteen patients (9 females and 7 males; mean age 45 years;
range 24–69 years) who were being investigated for upper
gastrointestinal symptoms were studied. Small intestinal
disease was excluded by endoscopy and routine histology.
Nineteen patients (11 females and 8 males; mean age 69
years; range 56–84 years) with colorectal cancer were stud-
ied. All endoscopic samples were obtained with informed
consent, and the study was approved by the Research and
Ethics committee of St. Vincent’s University Hospital, Dub-
lin.
4.2 Preparation of intestinal cells
Single-cell suspensions of epithelial layer and LP were pre-
pared from colonic and duodenal biopsy specimens as pre-
viously described [51, 52]. Briefly, biopsy samples were
rotated for 1 h at 37°C in calcium- and magnesium-free
Hanks Balanced Salt Solution (Gibco-BRL, Paisley, GB) sup-
plemented with 5% FCS, 1 mM DTT and 1 mM EDTA. This
results in removal of the epithelial layer, leaving the LP intact
and attached to the basement membrane. The resulting
single-cell suspension was washed in RPMI 1640 medium
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supplemented with 10% FCS and antibiotics, and viable
cells were enumerated by ethidium bromide and acridine
orange staining. To obtain LP cells, the remaining mucosal
tissue was placed in 5 ml supplemented RPMI 1640 medium
containing 130 U/ml collagenase (Type 1A, Sigma-Aldrich,
Ireland) and rotated for 3 h at 37°C. The resulting single-cell
suspension was washed in RPMI 1640 medium, and viability
counts were performed as above.
Surgically-resected intestinal tissue, which included unin-
volved colonic mucosa as well as tumor tissue, was pre-
pared similarly except that the tissue specimens were first
cut into fine pieces using a sterile scalpel and then treated
with 200 U/ml collagenase. The samples were subsequently
filtered through a nylon mesh and washed in RPMI medium
containing 10% FCS. Cell number and viability were deter-
mined as above. PBMC were prepared by standard density
gradient centrifugation (Lymphoprep, Nycomed Pharma,
Oslo, Norway).
4.3 Antibodies and flow cytometry
Fluorochrome-labeled monoclonal antibodies (mAb) specific
for human CD3, CD4, CD8, CD56, CD57, CD161, § g TCR,
+ ˇ TCR, HLA-DR, CD25, Fas ligand, IFN- + , TNF- § , IL-4 and
isotype matched controls were obtained from BD PharMin-
gen (Oxford, GB). Anti-V § 24 and anti-V g 11 mAb were
obtained from Coulter Immunotech (Marseilles, France).
Single-cell suspensions (1×105) derived from intestinal tis-
sue and peripheral blood were stained using specific mAb
as previously described [8, 51, 52] and analyzed by flow
cytometry using a FACScan and CellQuest software (Becton
Dickinson).
For measurement of intracellular cytokines (IFN- + , TNF- § ,
IL-4), freshly isolated intestinal cell suspensions were stimu-
lated with 10 ng/ml PMA and 1 ? g/ml ionomycin (Sigma-
Aldrich) for 4 h at 37°C in the presence of 10 ? g/ml brefel-
din A (Sigma-Aldrich). Cells were stained for surface expres-
sion of CD161 and CD3 and subsequently fixed and per-
meabilized before staining with mAb specific for the cyto-
kines and analysis by flow cytometry, as described previ-
ously [7].
4.4 Immunohistochemistry and immunofluorescence
For immunohistochemical staining, resected colonic tissue
specimens were fixed in formalin and embedded in paraffin.
Sections were subsequently dewaxed, microwave-heated
(3–5 min at 750 W in buffer containing 0.1 M sodium citrate
and 0.1 M citric acid, pH 6), rinsed in PBS and then incu-
bated with monoclonal anti-CD161 (5 ? g/ml) (Serotec,
Oxford, GB) or isotype-matched control antibodies. Staining
was revealed with a Vectstain Elite kit (Vector laboratories,
Peterborough, GB) and indirect immunoperoxidase staining.
For immunofluorescence studies, biopsy specimens were
mounted in cryopreservative embedding (OCT, Tissue Tec,
Finetec Europe, The Netherlands) and snap-frozen in liquid
nitrogen. Serial sections, cut at 5 ? m, were labeled with
50 ? g/ml monoclonal anti-CD161, 50 ? g/ml polyclonal anti-
CD3 (Dako, Ely, GB) or isotype-matched control antibodies.
Secondary antibodies consisted of Cy3-labelled goat anti-
biotin (Sigma-Aldrich) for CD161 and anti-rabbit FITC
(Sigma-Aldrich) for CD3. Fluorescent microscopy was
performed on a Nikon TE300 microscope.
4.5 Cytokine response to > -GalCer
Intestinal cells (1×106) were cultured in 24-well tissue culture
plates in the presence of 100 ng § -GalCer (Kirin Pharmaceu-
tical Research Laboratory, Gunma, Japan) [20–22], PHA or
vehicle as a control. After 48 h incubation, culture superna-
tants were collected, and IFN- + production was assayed by
ELISA according to the manufacturer’s instructions (R&D
Systems, Oxon, GB).
4.6 Statistical analyses
Flow cytometric results were expressed as the median val-
ues and range. The Mann-Whitney U test for non-parametric
data was used to analyze results. p values of less than 0.05
were considered significant.
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